Condition: Skin Inflammation · Immunosenescence · Inflammation · Sponsor: King's College London
This study will explore whether a daily probiotic drink containing Lactobacillus casei Shirota (LcS) can help improve immune function and reduce inflammation in women going through the menopausal transition. Hormonal changes during this stage of life can affect the immune system, gut health, and skin, sometimes leading to increased inflammation or conditions such as eczema, acne or rosacea. Participants will consume either a low-sugar LcS probiotic drink or a skimmed milk control drink every day for eight weeks. The study will assess markers of immune ageing, inflammation, skin health, wellbeing, and hormone levels. The results will help determine whether a safe, non-hormonal probiotic approach may support immune and skin health during the menopausal transition.
This description comes directly from the study's public registry record.
Prof. Wendy Hall · +44 (0)20 7848 4197 · wendy.hall@kcl.ac.uk
Andrea Du Preez, PhD · andrea.du_preez@kcl.ac.uk
Always discuss trial participation with your own doctor first.
| Metabolic Research Unit, 4th Floor (Corridor A), Franklin-Wilkins Building, KCL. | London, London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07341087